{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:22:10Z","timestamp":1764721330972,"version":"3.46.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jctube.2025.100565","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:52:45Z","timestamp":1759009965000},"page":"100565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tuberculosis reactivation in hematopoietic stem cell transplant recipients: a preemptive strategy in an endemic country"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-8808","authenticated-orcid":false,"given":"Irma Karen","family":"Pell\u00f3n-T\u00e9llez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar Eduardo","family":"Fernandez-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-8372","authenticated-orcid":false,"given":"Patricia","family":"Cornejo-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-404X","authenticated-orcid":false,"given":"Alexandra","family":"Martin-Onraet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Felipe","family":"Rubalcava-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Adriana","family":"Alvidrez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-6088","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Bonilla-Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Valero-Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda Lizeth","family":"Acosta-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2025.100565_b0005","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO\u2019s global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jctube.2025.100565_b0010","unstructured":"World Bank. Incidence of tuberculosis (per 100,000 people) [Internet]. Global Tuberculosis Report. World Health Organization; [citado 2025 Ago 13]. Available from:https:\/\/datos.bancomundial.org\/indicador\/SH.TBS.INCD."},{"key":"10.1016\/j.jctube.2025.100565_b0015","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jctube.2025.100565_b0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/pathogens12030362","article-title":"Management of tuberculosis infection: current situation recent developments and operational challenges","volume":"12","author":"Agbota","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.jctube.2025.100565_b0025","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S1473-3099(23)00372-9","article-title":"Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews","volume":"23","author":"Litvinjenko","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0030","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.bbmt.2020.02.018","article-title":"Frequency, risk factors, and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation","volume":"26","author":"Zeng","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jctube.2025.100565_b0035","doi-asserted-by":"crossref","unstructured":"Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann J-L, et al. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. Lancet Infect Dis 2022;22:e359\u201369. https:\/\/doi.org\/10.1016\/S1473-3099(22)00227-4.","DOI":"10.1016\/S1473-3099(22)00227-4"},{"key":"10.1016\/j.jctube.2025.100565_b0040","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/ciaa030","article-title":"Treatment of latent tuberculosis infection based on the interferon-\u03b3 release assay in allogeneic stem cell transplant recipients","volume":"71","author":"Park","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jctube.2025.100565_b0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American thoracic society\/infectious diseases society of America\/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0055","unstructured":"Centers for Disease Control and Prevention (CDC). Tuberculin Skin Testing [Internet]. Atlanta: CDC; 2023 Mar 28 [updated 2023 Mar 28; cited 2024 May 15]. Available from:https:\/\/www.cdc.gov\/tb\/hcp\/testing-diagnosis\/tuberculin-skin-test.html."},{"key":"10.1016\/j.jctube.2025.100565_b0060","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbmt.2020.03.013","article-title":"Latent tuberculosis in hematopoietic stem cell transplantation: diagnostic and therapeutic strategies to prevent disease activation in an endemic population","volume":"26","author":"Bourlon","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jctube.2025.100565_b0065","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41409-021-01329-3","article-title":"Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study","volume":"56","author":"de Oliveira","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jctube.2025.100565_b0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10096-023-04613-w","article-title":"Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay","volume":"42","author":"Castro-Lima","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","article-title":"Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis","volume":"17","author":"Auguste","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0080","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management [Internet]. Geneva: World Health Organization; 2018 [cited 2024 May 15]. 60 p. Available from:https:\/\/www.who.int\/publications\/i\/item\/9789241550239."},{"key":"10.1016\/j.jctube.2025.100565_b0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.crad.2023.04.014","article-title":"CT in the detection of latent tuberculosis: a systematic review","volume":"78","author":"Moore","year":"2023","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jctube.2025.100565_b0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13244-022-01255-y","article-title":"CT and 18F-FDG PET abnormalities in contacts with recent tuberculosis infections but negative chest X-ray","volume":"13","author":"Yoon","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.jctube.2025.100565_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-023-00661-4","article-title":"Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: a national population-based study, 2008\u20132020","volume":"23","author":"Hyun","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jctube.2025.100565_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12794","article-title":"Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation","volume":"20","author":"Agrawal","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0105","article-title":"The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: high incidence compared with general population","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100565_b0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1399-3062.2012.00765.x","article-title":"Comparison of the Q uanti FERON - TB G old In- Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation","volume":"15","author":"Moon","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijregi.2022.03.011","article-title":"A retrospective review of infections and outcomes within 100 days of hematopoietic stem cell transplantation: insights from a new transplant program in the Philippines","volume":"3","author":"Bello","year":"2022","journal-title":"IJID Regions"},{"key":"10.1016\/j.jctube.2025.100565_b0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/sj.bmt.1703092","article-title":"Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Ku","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jctube.2025.100565_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the national tuberculosis controllers association and CDC, 2020","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recommendations and Reports"},{"key":"10.1016\/j.jctube.2025.100565_b0130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cid\/ciz048","article-title":"Risk of latent tuberculosis reactivation after hematopoietic cell transplantation","volume":"69","author":"Cheng","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jctube.2025.100565_b0140","article-title":"Case Report: active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jctube.2025.100565_b0145","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: an old disease in a new context","volume":"21","author":"Langan","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jctube.2025.100565_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"Anand","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.jctube.2025.100565_b0155","doi-asserted-by":"crossref","first-page":"20402","DOI":"10.1038\/s41598-019-56013-w","article-title":"Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jctube.2025.100565_b0160","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.transproceed.2024.05.034","article-title":"Cisplatin as a viable and secure alternative to carmustine in beam-based conditioning for autologous hematopoietic stem cell transplantation in patients with lymphoma","volume":"56","author":"Acosta-Maldonado","year":"2024","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jctube.2025.100565_b0165","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031786","article-title":"Latent tuberculosis in adult hematopoietic stem cell transplantation recipients: clinical experience from a previously endemic population","volume":"101","author":"Mert","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.jctube.2025.100565_b0170","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.3390\/ijerph191710693","article-title":"Latent tuberculosis infection in haematopoietic stem cell transplant recipients: a retrospective italian cohort study in tor vergata university hospital, rome","volume":"19","author":"Compagno","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jctube.2025.100565_b0175","article-title":"A targeted screening program for latent tuberculosis infection among hematopoietic cell transplant recipients. open forum","volume":"7","author":"Sosa-Moreno","year":"2020","journal-title":"Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0180","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12912","article-title":"The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: a retrospective cohort study from a center in Turkey","volume":"20","author":"Ak\u0131","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5588\/ijtld.14.0301","article-title":"Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study","volume":"19","author":"Fan","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jctube.2025.100565_b0190","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. a TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:19:25Z","timestamp":1764721165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579425000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"alternative-id":["S2405579425000567"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100565","relation":{},"ISSN":["2405-5794"],"issn-type":[{"type":"print","value":"2405-5794"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis reactivation in hematopoietic stem cell transplant recipients: a preemptive strategy in an endemic country","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100565"}}